[Robot-assisted laparoscopic inferior vena cava segmental resection for renal tumor with tumor thrombus invading the vascular wall].

Q3 Medicine
北京大学学报(医学版) Pub Date : 2025-08-18
S Liu, Z Liu, Y Guan, G Wang, X Tian, H Zhang, L Liu, L Ma, S Zhang
{"title":"[Robot-assisted laparoscopic inferior vena cava segmental resection for renal tumor with tumor thrombus invading the vascular wall].","authors":"S Liu, Z Liu, Y Guan, G Wang, X Tian, H Zhang, L Liu, L Ma, S Zhang","doi":"","DOIUrl":null,"url":null,"abstract":"<p><strong>Objective: </strong>To evaluate the safety and oncological outcomes of robot-assisted laparoscopic inferior vena cava (IVC) segmental resection in renal tumor with IVC tumor thrombus (IVCTT).</p><p><strong>Methods: </strong>Clinical data from renal tumor patients undergoing robot-assisted laparoscopic IVC segmental resection at Peking University Third Hospital from Jan. 2021 to Feb. 2025 were retrospectively analyzed. Data collection included baseline demographics, tumor characteristics, perioperative parameters, and follow-up outcomes. Surgical records and pathological reports were retrieved from the electronic medical record system. Continuous variables were presented as median (<i>P</i><sub>25</sub>, <i>P</i><sub>75</sub>), and categorical variables as frequency (percentage).</p><p><strong>Results: </strong>Forty-four patients were enrolled. The cohort comprised 31 males and 13 females, with a median age of 62 (55, 68) years. Right-sided tumors were observed in 39 cases and left-sided in 5 cases. Median tumor diameter was 8.1 (6.1, 10.1) cm. Mayo classifications included grade Ⅱ (<i>n</i>=37), Ⅲ (<i>n</i>=6), and Ⅳ (<i>n</i>=1). Neoadjuvant therapy was administered to 23 patients. Seventeen patients were complicated by IVC bland thrombus. Median operative time was 224.0 (167.3, 303.8) min, with intraoperative blood loss of 500.0 (300.0, 850.0) mL. Transfusion was administered to 19 patients, with a median blood transfusion of 800.0 (400.0, 1 200.0) mL. Postoperative complications occurred in 25 cases (56.8%), classified as Clavien-Dindo grade Ⅰ (<i>n</i>=8) and grade Ⅱ (<i>n</i>=17). Procedure-specific complications included deep vein thrombosis (<i>n</i>=6), transfusion-requiring anemia (<i>n</i>=5), lower extremity edema (<i>n</i>=2), and pulmonary embolism (<i>n</i>=2), with no procedure- related mortality. Median postoperative serum creatinine was 116.0 (86.5, 157.5) μmol/L. Pathological examination identified clear cell renal cell carcinoma as the predominant subtype, observed in 34 cases (77.3%). Pathological staging revealed T3b (<i>n</i>=12), T3c (<i>n</i>=29), and T4 (<i>n</i>=3) disease, with nodal involvement (N1) in 8 cases and distant metastasis (M1) in 17. At a median follow-up of 10 months (range: 1-49 months), cancer-specific mortality occurred in 3 patients, while 1 succumbed to other causes. Disease progression included pulmonary metastasis (<i>n</i>=5), hepatic metastasis (<i>n</i>=4), and local recurrence (<i>n</i>=4). Adjuvant therapy regimens comprised targeted-immunotherapy combinations (<i>n</i>=9) and targeted monotherapy (<i>n</i>=18).</p><p><strong>Conclusion: </strong>Robot-assisted laparoscopic IVC segmental resection achieves precise thrombus removal with confirmed short-term efficacy in renal tumor with IVCTT, though vigilance against vascular complications remains critical.</p>","PeriodicalId":8790,"journal":{"name":"北京大学学报(医学版)","volume":"57 4","pages":"796-802"},"PeriodicalIF":0.0000,"publicationDate":"2025-08-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12330951/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"北京大学学报(医学版)","FirstCategoryId":"3","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0

Abstract

Objective: To evaluate the safety and oncological outcomes of robot-assisted laparoscopic inferior vena cava (IVC) segmental resection in renal tumor with IVC tumor thrombus (IVCTT).

Methods: Clinical data from renal tumor patients undergoing robot-assisted laparoscopic IVC segmental resection at Peking University Third Hospital from Jan. 2021 to Feb. 2025 were retrospectively analyzed. Data collection included baseline demographics, tumor characteristics, perioperative parameters, and follow-up outcomes. Surgical records and pathological reports were retrieved from the electronic medical record system. Continuous variables were presented as median (P25, P75), and categorical variables as frequency (percentage).

Results: Forty-four patients were enrolled. The cohort comprised 31 males and 13 females, with a median age of 62 (55, 68) years. Right-sided tumors were observed in 39 cases and left-sided in 5 cases. Median tumor diameter was 8.1 (6.1, 10.1) cm. Mayo classifications included grade Ⅱ (n=37), Ⅲ (n=6), and Ⅳ (n=1). Neoadjuvant therapy was administered to 23 patients. Seventeen patients were complicated by IVC bland thrombus. Median operative time was 224.0 (167.3, 303.8) min, with intraoperative blood loss of 500.0 (300.0, 850.0) mL. Transfusion was administered to 19 patients, with a median blood transfusion of 800.0 (400.0, 1 200.0) mL. Postoperative complications occurred in 25 cases (56.8%), classified as Clavien-Dindo grade Ⅰ (n=8) and grade Ⅱ (n=17). Procedure-specific complications included deep vein thrombosis (n=6), transfusion-requiring anemia (n=5), lower extremity edema (n=2), and pulmonary embolism (n=2), with no procedure- related mortality. Median postoperative serum creatinine was 116.0 (86.5, 157.5) μmol/L. Pathological examination identified clear cell renal cell carcinoma as the predominant subtype, observed in 34 cases (77.3%). Pathological staging revealed T3b (n=12), T3c (n=29), and T4 (n=3) disease, with nodal involvement (N1) in 8 cases and distant metastasis (M1) in 17. At a median follow-up of 10 months (range: 1-49 months), cancer-specific mortality occurred in 3 patients, while 1 succumbed to other causes. Disease progression included pulmonary metastasis (n=5), hepatic metastasis (n=4), and local recurrence (n=4). Adjuvant therapy regimens comprised targeted-immunotherapy combinations (n=9) and targeted monotherapy (n=18).

Conclusion: Robot-assisted laparoscopic IVC segmental resection achieves precise thrombus removal with confirmed short-term efficacy in renal tumor with IVCTT, though vigilance against vascular complications remains critical.

[机器人辅助腹腔镜下腔静脉段性切除术治疗肿瘤血栓侵犯血管壁]。
目的:评价机器人辅助腹腔镜下腔静脉(IVC)分段切除肾肿瘤伴下腔静脉肿瘤血栓(IVCTT)的安全性和肿瘤预后。方法:回顾性分析北京大学第三医院2021年1月至2025年2月行机器人辅助腹腔镜下腔静脉段切除术的肾肿瘤患者的临床资料。数据收集包括基线人口统计学、肿瘤特征、围手术期参数和随访结果。从电子病历系统中检索手术记录和病理报告。连续变量用中位数表示(P25, P75),分类变量用频率表示(百分比)。结果:44例患者入组。该队列包括31名男性和13名女性,中位年龄为62(55,68)岁。右侧肿瘤39例,左侧肿瘤5例。肿瘤中位直径8.1 (6.1,10.1)cm。Mayo分级包括Ⅱ(n=37)、Ⅲ(n=6)和Ⅳ(n=1)。23例患者接受新辅助治疗。17例合并静脉血栓。手术时间中位数为224.0 (167.3,303.8)min,术中出血量500.0 (300.0,850.0)mL。19例患者输血,中位数输血800.0 (400.0,1 200.0)mL。术后发生并发症25例(56.8%),分为Clavien-Dindo级Ⅰ(n=8)和Ⅱ级(n=17)。手术特异性并发症包括深静脉血栓形成(n=6)、需要输血的贫血(n=5)、下肢水肿(n=2)和肺栓塞(n=2),无手术相关死亡。术后血清肌酐中位数为116.0 (86.5,157.5)μmol/L。病理检查确定透明细胞肾细胞癌为主要亚型,34例(77.3%)。病理分期为T3b (n=12)、T3c (n=29)、T4 (n=3),伴淋巴结累及(N1) 8例,远处转移(M1) 17例。在中位随访10个月(范围:1-49个月),3例患者发生癌症特异性死亡,1例死于其他原因。疾病进展包括肺转移(n=5)、肝转移(n=4)和局部复发(n=4)。辅助治疗方案包括靶向免疫治疗联合(n=9)和靶向单药治疗(n=18)。结论:机器人辅助腹腔镜下腔静脉切开术对伴有IVCTT的肾肿瘤实现了精确的血栓清除,短期疗效明确,但对血管并发症的警惕仍然至关重要。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
北京大学学报(医学版)
北京大学学报(医学版) Medicine-Medicine (all)
CiteScore
0.80
自引率
0.00%
发文量
9815
期刊介绍: Beijing Da Xue Xue Bao Yi Xue Ban / Journal of Peking University (Health Sciences), established in 1959, is a national academic journal sponsored by Peking University, and its former name is Journal of Beijing Medical University. The coverage of the Journal includes basic medical sciences, clinical medicine, oral medicine, surgery, public health and epidemiology, pharmacology and pharmacy. Over the last few years, the Journal has published articles and reports covering major topics in the different special issues (e.g. research on disease genome, theory of drug withdrawal, mechanism and prevention of cardiovascular and cerebrovascular diseases, stomatology, orthopaedic, public health, urology and reproductive medicine). All the topics involve latest advances in medical sciences, hot topics in specific specialties, and prevention and treatment of major diseases. The Journal has been indexed and abstracted by PubMed Central (PMC), MEDLINE/PubMed, EBSCO, Embase, Scopus, Chemical Abstracts (CA), Western Pacific Region Index Medicus (WPR), JSTChina, and almost all the Chinese sciences and technical index systems, including Chinese Science and Technology Paper Citation Database (CSTPCD), Chinese Science Citation Database (CSCD), China BioMedical Bibliographic Database (CBM), CMCI, Chinese Biological Abstracts, China National Academic Magazine Data-Base (CNKI), Wanfang Data (ChinaInfo), etc.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信